Psychedelics GH Research skyrockets on 5-MeO-DMT drug’s depression treatment breakthrough Shares surged by nearly 125% during pre-market hours Rowan DunneFebruary 3, 2025
Psychedelics Biomind Labs develops sublingual psychedelic drug to treat Alzheimer’s The under-the-tongue drug candidate will be studied in a Phase II clinical trial prior to commercialization Rowan DunneDecember 30, 2022